Cargando…
Neuraminidase inhibitor treatment is associated with decreased mortality in COVID-19 patients: a retrospective analysis
AIMS: The aim of this study was to investigate the effects of Neuraminidase inhibitors (NI) on COVID-19 in a retrospective study. METHODS AND RESULTS: The study included an overall COVID-19 patients (n = 3267) and a 1:1 propensity score-matched patients (n = 972). The levels of plasma N-acetylneuram...
Autores principales: | Wu, Junfang, Zhao, Mingming, Wei, Haoran, Li, Chenze, Hu, Dong, Zheng, Lemin, Wang, Dao Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992306/ https://www.ncbi.nlm.nih.gov/pubmed/35294004 http://dx.doi.org/10.1093/ehjcvp/pvac018 |
Ejemplares similares
-
Association of Systemic Trimethyllysine With Heart Failure With Preserved Ejection Fraction and Cardiovascular Events
por: Wei, Haoran, et al.
Publicado: (2022) -
The SARS-CoV-2 induced targeted amino acid profiling in patients at hospitalized and convalescent stage
por: Wu, Junfang, et al.
Publicado: (2021) -
Inhibition of neuraminidase by Ganoderma triterpenoids and implications for neuraminidase inhibitor design
por: Zhu, Qinchang, et al.
Publicado: (2015) -
The role of neuraminidase inhibitors in the treatment and
prevention of influenza
por: Naem, Shahrour
Publicado: (2001) -
Consecutive influenza surveillance of neuraminidase mutations and neuraminidase inhibitor resistance in Japan
por: Chong, Yong, et al.
Publicado: (2019)